<DOC>
	<DOCNO>NCT00219466</DOCNO>
	<brief_summary>To evaluate whether Desitin ; Zinc Oxide Diaper Rash Ointment ( Desitin Original ) Desitin Creamy ; Zinc Oxide Diaper Rash Ointment ( Desitin Creamy ) provide relief sign symptom associate diaper rash 12 24 hour product application .</brief_summary>
	<brief_title>Clinical Study Evaluate Efficacy Safety Two Marketed Investigational Products Children With Diaper Rash</brief_title>
	<detailed_description>Subjects receive application investigational product follow gentle cleanse diaper zone every diaper change follow bath child 24 hour period . Efficacy assess study documentation severity diaper rash . Results five anatomic area overall severity score evaluator 's assessment , parent/guardian 's assessment indicate product significantly effective ( P &lt; 0.05 relieve diaper dermatitis ( rash ) 12 24 hour treatment . Safety assess report adverse event course study . Overall , report adverse event condition protocol indicate investigational product would appear safe intend use .</detailed_description>
	<mesh_term>Diaper Rash</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Zinc Oxide</mesh_term>
	<criteria>Healthy male female child , 236 month age Wear diapers 24 hour per day Present test facility enrollment baseline diaper rash receive `` Overall Severity Score '' great equal 1.5 determine trained evaluator Parent/guardian sign informed consent Parent/guardian willing use test product diaper area trial Parent/guardian willing ensure child continue wear usual brand diaper continue clean child diaper change use usual product method exception ointment , lotion , cream powder trial Parent/guardian willing refrain changing product whose use may effect child 's skin condition trial , i.e. , laundry detergent , fabric softener , product use bathe child A Fitzpatrick Skin Type IIV Illness within 4 day precede enrollment Currently toilet train Active dermatological condition diaper rash may affect trial result History recurrent dermatological condition diaper rash may affect trial result Concomitant use medication may affect trial result Known sensitivity ingredient trial medication Known sensitivity , rash abnormal skin reaction topical systemic medication cleanse product within one year trial initiation Other severe acute chronic medical condition may increase risk associate trial participation may interfere interpretation result</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>